Part 3: Limited-Stage Hodgkin Lymphoma

Sai Ravi Pingali, MD

Fellow, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Jasleen Randhawa, MD

Fellow, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Timothy S. Fenske, MD

Associate Professor of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Question 5

A 25-year-old woman diagnosed with nodular lymphocyte-predominant HL has left cervical and left axillary lymphadenopathy. She denies having any B symptoms. Her complete blood count, lactate dehydrogenase concentration, and ESR are normal. What would be the recommended treatment option for this patient?

  •   Rituximab
  •   Rituximab and IFRT
  •   IFRT
  •   ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) therapy x 2 cycles
    followed by IFRT
  •   C or D

Updated 07/16/2012 • jdw | Copyright ©2014 Turner White Communications